The signal transducing protein Stat3 activates gene transcription in cells in response to multiple cytokines. Constitutive activation of Stat3 has been observed in solid tumors including head and neck squamous cell carcinoma. Stat3 activation in cancer has been associated with autocrine stimulatory loops and is believed to convey a growth advantage to cells. We now demonstrate ligandindependent activation of Stat3 by high cell density in multiple cancer cell lines. Activation of Stat3 is associated with antiproliferative rather than proliferative conditions. Interference with cdk2 activity upregulates Stat3 phosphorylation and Stat3-directed DNA-binding activity. Our data supports a model in which Stat3 activity is partially suppressed by cdk2 in growing cells and derepressed upon cell confluence.
Introduction
STAT proteins are a family of transcriptional activators, which have been shown to modulate gene expression in response to multiple cytokines (for review see Bromberg and Darnell, 2000; Jove, 2000 #803) . STAT proteins can be activated by phosphorylation either by JAK kinases that are associated with active cytokine receptors, or by nonreceptor tyrosine kinases. The essential role of STAT proteins in mediating cytokine signaling is manifested by the phenotype of STAT knockout mice, which parallel defects that arise from cytokine receptor or cytokine knockouts (for review, see Takeda and Akira, 2000) . Unlike other STAT knockouts, the loss of Stat3 results in embryonic lethality, indicative of a nonredundant requirement for this factor. Conditional Stat3 knockouts have underscored a critical role for Stat3 in the function of T cells, macrophages, keratinocytes, and the mammary gland (Takeda and Akira, 2000) .
The control of Stat3 activity has been shown to be important in several biological settings. Stat3 activation has been linked to both growth arrest and to aberrant cell growth, to apoptosis and antiapoptosis, and to cell migration (Akira, 2000) . During hematopoiesis, Stat3 is required for myeloid differentiation (Steinman and Iro, 1999; McLemore et al., 2001) and facilitates differentiation-coupled growth arrest by inducing the transcription of the cell cycle inhibitor p27 (de Koning et al., 2000) . In contrast, several leukemogenic oncogenes have been found to promote constitutive Stat3 activation in cell line models and in leukemic blasts. Overexpression and/ or heightened activation of Stat3 is a prominent feature of cancers in addition to leukemias. Fibroblasts engineered to express a dominant-active Stat3 demonstrated anchorage independence and formed tumors in nude mice, thus establishing Stat3 as an oncogene (Bromberg et al., 1999) . We have similarly found that xenografts of head and neck cancer cells constitutively expressing Stat3C form more aggressive and larger tumors (Kijima et al., 2002) . This may result from an antiapoptotic function of Stat3, which has been observed in many (but not all) Chapman et al., 2000) cell types. We have previously shown that constitutive Stat3 signaling inhibits apoptosis in a model of squamous cell carcinoma (Grandis et al., 2000a) , and that growth of head and neck cancer cells is inhibited by dominant-negative Stat3 (Grandis et al., 1998a) . In squamous cell carcinoma, breast cancer, and prostate cancer, high levels of constitutive Stat3 activation are thought to arise from autocrine stimulatory routes (Song and Grandis, 2000; Berclaz et al., 2001; Giri et al., 2001; Li and Shaw, 2002) .
While Stat3 activation by soluble cytokines has been well described, there is little known about modulation of the Stat3 signaling pathway by cell-cell interactions, and particularly by cellular signals associated with cell confluence. In this work, we report ligand-independent activation of Stat3 by cell confluence. Activation results in part from inhibition of cyclin-dependent kinase-2, suggesting the existence of an 'inside-out' signaling pathway involving cell cycle inhibitors and Stat3.
Results

Upregulation of Stat3 DNA-binding activity with cell confluence
We studied the relation of Stat3 signaling and cell confluence in squamous cell carcinoma of the head and neck (SCCHN) cell lines, in which we had shown that Stat3 was required for cell growth (Grandis et al., 1998a (Grandis et al., , 2000a . In these cell lines, Stat3 activation was believed to result from an autocrine loop involving EGFR-TGFalpha (Grandis and Tweardy, 1993; Grandis et al., 1998b) , which was necessary for the growth of SCCHN cells in vitro and in vivo (He et al., 1998; Endo et al., 2000) . We hypothesized that autocrine induction of Stat3 would facilitate the ability of these cells to escape contact inhibition of growth. The density-dependent growth of several SCCHN cell lines was therefore characterized, as well as their ability to induce the cyclin-dependent kinase inhibitors (cdki's) p21 and p27 upon cell confluence. Figure 1a demonstrates that SCCHN cell lines UM-22B (22b) and PCI-37A (37a) continued to grow for several days after attaining visual cell confluence, whereas the SCCHN cell line PCI-15B (15b) exhibited confluence-dependent growth arrest. Analysis of cell cycle modulator expression showed that the cdki's p21 and p27 were upregulated in confluent UM-22B and PCI-37A cells and further upregulated in postconfluent cells harvested 2 days after visual confluence (Figure 1b) .
Interestingly, PCI-15B cells, which grew most slowly, did not significantly alter cdki expression at confluence. The expression of Stat3 protein was constant at all cell densities. Surprisingly, Stat3 activation increased dramatically for each cell line in proportion to cell density ( Figure 1c) . This was not a function of cell culture duration, because the same effect was seen whether cells were allowed to grow to high density, or if cells were split and seeded in equivalent numbers into a small (confluent) and large (subconfluent) dish and harvested concurrently (data not shown). Stat3 was activated at high cell density both in cells that grew past confluence (UM-22B, PCI-37A) and cells that did not (PCI-15B), indicating that activated Stat3 was not sufficient to overcome contact inhibition of growth. As shown in Figure 1e , even though UM-22B cells continued to accumulate postconfluence, their rate of cell cycling slowed. In fact, Stat3 was activated concurrently with cell cycle inhibition, as manifested by Rb hypophosphorylation ( Figure 1d ). Stat3 activation could not be accounted for by changes in the level of Stat3 protein (Figure 1b, d) .
We considered that Stat3 activation at high cell confluence could reflect disproportionate expression of a stimulatory cytokine in confluent cell cultures. Therefore, supernatant swap experiments were conducted in which supernatants from subconfluent cells were applied to confluent cells, and confluent cell supernatants were applied to subconfluent cells for 8 h. As shown in Figure 1f , the level of Stat3 activation was not affected by switching of cell supernatants, indicating that it did not result from differential expression of a soluble factor.
Stat3 activation by cell confluence was not confined to SCCHN cells. Figure 2 demonstrates that substantial upregulation of Stat3 DNA binding occurred with confluence in transformed cell lines of bladder, kidney, breast, and fibroblast origin.
Confluence-mediated Stat3 activation in SCCHN cells is EGFR-independent
The inability of supernatant swapping to recapitulate Stat3 activation associated with confluence suggested that this phenomenon was ligand-independent. In order to further evaluate this possibility, we determined whether the EGFR-specific inhibitor PD153035 was capable of blocking density-dependent Stat3 activation in UM-22B SCCHN cells. EGFR activation is the primary mechanism for ligand-mediated Stat3 activation in these cells (Grandis et al., 2000b) .
Results are shown in Figure 3a . TGF-alpha was added in the absence of serum in order to minimize basal levels of Stat3 activation and optimize responsiveness to exogenous TGF-alpha. Figure 3a demonstrates that under serum-starved conditions, Stat3 activation was lower than in the presence of serum. There was a marked increase in Stat3 activation when cells were confluent. Confluence-activated Stat3 was not inhibited by the EGFR inhibitor PD153035 at a concentration at which it effectively blocked Stat3 activation by high levels of exogenous TGF-alpha. This finding further supported the conclusion that confluence increased Stat3 through a ligand-independent mechanism. It is notable that whereas confluence upregulated Stat3, other antiproliferative conditions (e.g. serum starvation) did not do so.
The lack of a requirement for EGFR signaling for Stat3 upregulation was confirmed by measuring Stat3 activity in EGFR-knockout mouse fibroblasts grown to different densities. As shown in Figure 3c , Stat3 activity also increased with density in these knockout cells.
Receptor-mediated activation of Stat3 has been associated with the formation of Stat3-Rac1 complexes; for instance, IL-6 activation of Stat3 appears to require Rac1 (Simon et al., 2000; Faruqi et al., 2001) . Figure 3b shows immunoprecipitation experiments in UM-22B cells that demonstrated that the amount of tyrosine 705-phosphoStat3 in complex with Rac1 did not change with cell density. Confluence-mediated Stat3 activation therefore did not depend on altered interactions with Rac1. It is notable that increased cell density was associated with an increase in phosphotyrosine-Stat3 which immunoprecipitated with antibody directed against Stat3. This indicates that there is an increase in Stat3 phosphorylation with increased cell density (see also Figures 4c, 5b ).
Stat3 phosphorylation is induced by cdk2 inhibition As shown in Figure 1 , the level of cdk inhibitors rose as SCCHN cells became confluent and continued to rise as they were postconfluent. Analysis of cdk2-kinase activity in UM-22b and in PCI-15B cells demonstrated that cdk2-kinase activity decreased concurrently with an increase in Stat3 activity (Figure 4a ). Since Stat3 activation did not precede the decrease in cdk2 kinase activity, we considered that changes in Stat3 activity might occur downstream of cdk2 inhibition. In order to test whether cdk2 inhibition caused a feedback increase in Stat3 activity, UM-22B cells were incubated with the cdk2 inhibitor roscovitine or were transduced with 
Stat3 activation and cell-cell interactions
We considered it likely that cell-cell interactions occurring at high cell density contributed to Stat3 activation. In order to examine this in more detail, experiments were conducted using MDCK cells, which grow in a tight monolayer which can be disrupted with brief exposure to trypsin. Cells that were 48 h postconfluence were exposed to PBS for 10 min or to trypsin to disrupt cell-cell contacts. Trypsin-treated cells continued to adhere to the flask but assumed a rounded morphology (Figure 5a ). Cells were then re-exposed to growth medium for 30 min, following which adherent cells were harvested for gel shift analysis. As shown in Figure 5a , exposure to trypsin decreased Stat3 binding to DNA. This was associated with decreased Stat3 phosphorylation (Figure 5b ). Based on our data suggesting an inverse relation between cdk2 activity and Stat3 activation, we measured cdk2 kinase activity in low-and high-density MDCK cells and in trypsindisrupted cells. As shown in Figure 5b , high-density cells contain higher levels of phospho-Stat3 and low cdk2 kinase activity. Disruption of cell-cell contacts with trypsin lowered phospho-Stat3 levels and activated cdk2 kinase.
Discussion
The present investigation has identified ligand-independent upregulation of Stat3 phosphorylation and Stat3 DNA-binding activity by cell confluence in numerous cell lines. Stat3 activation is density-dependent and continues to increase following cell confluence. Stat3 activation coincided with a decrease in Rb phosphorylation and with downmodulation of cdk2-kinase activity. Dominant-negative cdk2 increased Stat3 tyrosine phosphorylation, indicating that cdk2 inhibition could be contributing to confluence-dependent increases in Stat3 activity.
The finding of increased Stat3 activity in confluent head and neck cancer cells compared with fastergrowing subconfluent cells was somewhat surprising, given the association of Stat3 signaling with oncogenesis in these cells (Grandis et al., 1998a) . Since activated Stat3 is insufficient to sustain SCCHN cell proliferation at high density (Figure 1 ), the oncogenicity of Stat3 more likely results from its antiapoptotic function (Grandis et al., 2000a) than by augmenting proliferation.
Our evidence indicated that confluence-mediated Stat3 activation was ligand-independent. Stat3 was not activated by incubation of subconfluent cells with confluent cell supernatent, nor was Stat3 suppressed in Stat3 activation by cell density and cdk2 inhibition RA Steinman et al confluent SCCHN cells by EGFR inhibitors. Although these manipulations would not prevent Stat3 activation by an internal autocrine loop, it is unlikely that such an autocrine mechanism would be coupled to cell density. Autocrine activation of Stat3 and confluence-mediated activation may represent independent pathways whose relative importance varies with the cellular environment. Cell-cell adherence facilitates Stat3 activation in confluent cells, as manifested by the ability of brief trypsin exposure to downmodulate Stat3 activation in MDCK cells. The upregulation of Stat3 with cell density may not be universal -we have become aware that in Caco-2 cells Stat3 activation increases with confluence and decreases postconfluence (Wang and Evers, 1999) . Additional investigation will determine which cell-cell signaling pathways are involved in Stat3 activation at high cell density. In keeping with other reports (Xie et al., 2001) , we have found focal adhesion kinase (FAK) to exist in complex with phospho-Stat1 in cells used in this study (data not shown), but have no evidence of FAK-Stat3 complex formation at high or low cell densities.
The association of Stat3 activation with cell density and decreased growth led us to speculate that there might be a feedback mechanism between cell cycle regulators and Stat3. We noted decreased activity of cyclin-dependent kinase-2 at high cell confluence, when Stat3 is activated. Direct dominant-negative protein transduction and cdk2-inhibitor experiments indicated that cyclin-dependent kinase-2 suppresses Stat3 phosphorylation. Since cdk2 activity affects Stat3 phosphorylation, it most likely acts at a proximal point in the transduction pathway. In rat hepatocytes, Cdk2 has been reported to modulate receptor activation at the plasma membrane by regulating endocytosis (Gaulin et al., 2000) . We have shown that the cdk2-inhibitor p27 also may interact with signaling complexes by localizing to lipid rafts (Yaroslavskiy et al., 2001 ) Such localization could facilitate 'inside-out' signaling of cell cycle regulators to alter signal transduction at the membrane. Indeed, recent reports that Stat3 localizes to rafts (Sehgal et al., 2002) and that stat3 undergoes endocytosis during signaling (Bild et al., 2002) indicate that Stat3 may share topographic proximity with cdk2 and cdk2 inhibitors at the cell membrane. Our finding of Stat3 upregulation by cdk2 inhibitors is consistent with the report that antisense p27Kip1 decreased Stat3 activity in keratinocytes (Hauser et al., 1998) . UM-22B and PCI-15B cells were grown for up to 10 days as indicated. Cells were confluent on day 4. Cdk2 activity was measured for each timepoint; a parallel sample was harvested for Stat3. activity. Stat-3 antibody supershifted bands on gelshift are shown. (b) Direct transduction of dominant-negative cdk2 protein activates Stat3. UM-22B cells were exposed overnight to 150 nm cell-permeable DN-cdk2 (TAT-cdk2DN) or to GFP control (TAT-GFP) and Stat3 activity determined on gel shift assay. Activation of Stat3 by 12 mg/ml roscovitine is also evident. Two independent experiments are shown. (c) Increased phosphorylation of Stat3 by dominant-negative cdk2 and by confluence. Western blot of 50 mg protein extract is shown. Cells were exposed to media alone or to TAT fusion proteins as indicated overnight at indicated cell densities and extracts were blotted with Try705-specific anti-Stat3 antibody. Ponceau staining confirmed equivalent protein loading in each lane Our data support a model in which Stat3 activity is partially suppressed by cdk2 in growing cells and is derepressed upon cell confluence. Even in cells that have attained visual confluence and concommitant Stat3 activation, inhibition of residual cdk2 activity further augments Stat3 activation. On the other hand, growth arrest through serum starvation did not suffice to activate Stat3, indicating that a serum component as well as low cdk2 activity is required for optimal Stat3 activation.
The mechanism through which cdk2 suppresses Stat3 phosphorylation is unknown. We have not been able to demonstrate a direct interaction between cdk2 and Stat3. It is conceivable that cdk2 acts in tandem with known negative regulators of Stat3. These include suppressor of cytokine signaling-3) (SOCS3) (Suzuki et al., 2001 ; for review Krebs and Hilton, 2001; Yasukawa et al., 2000) , protein inhibitor of activated Stat3 (PIAS) (Junicho et al., 2000) , cyclin D1 (Bienvenu et al., 2001) , and the cell cycle modulator p21 (Coqueret and Gascan, 2000) . Of these, only SOCS3 has been noted to inhibit Stat3 phosphorylation; the other inhibitors either inhibit nuclear translocation of phosphorylated Stat3 or inhibit transcriptional activation by DNA-bound Stat3. We therefore considered whether cdk2 might suppress Stat3 by increasing the activity of SOCS3. We noted a potential cdk2 phosphorylation site (SPPR; Kitagawa et al., 1996) and cyclin-interacting sites (RPL; Kitagawa et al., 1996) in the SOCS3 sequence. However, we could not demonstrate changes in SOCS3 protein levels with confluence, nor association of SOCS3 with cdk2 nor confluence-dependent changes in SOCS3 phosphorylation (data not shown).
Stat3 upregulation following cell confluence may contribute to the decreased growth rate of these cells. Among Stat3 target genes, some are antiproliferative including p27 (de Koning et al., 2000) and p21 (Sinibaldi et al., 2000) . Suppression of Stat3 activation in growing cells may help to suppress such antiproliferative gene expression. On the other hand, it is possible that the increase in Stat3 activation represents a feedback mechanism to oppose the pathways limiting the growth of confluent cells. Such a premise would raise the question of why Stat3 would be insufficient to promote proliferation. It is notable that levels of antiproliferative Stat3 targets (e.g. p27) are upregulated following cell confluence, whereas Stat3-responsive proliferative genes (e.g. myc, cyclin D1) are not (data not shown). Whether these target gene expression patterns reflect selective Stat3 binding to target promoter sequences as a function of cell confluence is under study.
The enhanced oncogenicity of Stat3-expressing cells may arise from density-dependent increase in Stat3 activation. Cancer cell lines have been shown to exhibit increased resistance to apoptosis upon cell confluence (Garrido et al., 1997; Dimanche-Boitrel et al., 1998) Such apoptosis resistance has been mimicked by transfection of constitutively active Stat3 constructs (Shen et al., 2001) . Protein interactions involved in the cell-cell activation of Stat3 may therefore constitute a reasonable therapeutic target.
Other biologic processes may be affected by confluence-associated changes in Stat3 activity. For instance, increased Stat3 signaling may modulate expression and/or activity of integrins involved in cell adherence (Wooten et al., 2000) . To the extent that a cell-density-associated pathway of Stat3 activation is recruited at distinct stages in development, this pathway could also contribute to the critical role for Stat3 in embryogenesis.
Materials and methods
Cell lines
Head and neck squamous cell carcinoma cell lines PCI-37A, UM-22B and PCI-15B, NIH-3T3 cells, MDCK type II kidney cells, ZRP breast cancer cells, and TSU bladder cancer cells were grown in DMEM medium (Mediatech, Herndon, VA, USA) containing 10% fetal bovine serum (FBS, Life Technologies, Frederick, MD, USA), 100 mg/ml penicillin, and streptomycin. Medium was supplemented with 10 nm Bestradiol for ZRP cells. MDCK type I cells were cultured in DMEM/F12 medium (ATCC, Manassus, VA, USA) with 10% FBS. All cells were split to sustain log-phase growth and new vials were thawed every 2 months.
Immunoprecipitations
Cells were washed with PBS and lysed in cold immunoprecipitation buffer (50 mm Tris, pH 7.5, 150 mm NaCl, 50 mm NaF, 1 mm NaVO3, 1 mm DTT, 0.5%NP-40, 0.1% protease inhibitor, 0.1% phosphatase inhibitor, 5 mg/ml PMSF, 1 mg/ml leupeptin, from Sigma, St. Louis, MO, USA). Precleared lysate (100 mg) in 1 ml IP buffer was incubated overnight with 1 mg of rabbit IgG (Santa Cruz, Santa Cruz, CA, USA), 1 mg of polyclonal anti-Stat3 (Cell Signaling Technology, Beverly, MA, USA) or 1 mg of anti-Rac1 (sc271AC, Santa Cruz) and nutated at 41 overnight. Protein A/G Plus (40 ml) beads (Santa Cruz) were added, and after an additional 2 h of mixing at 41, beads were pelleted followed by five washes in IP buffer, beads were boiled in Laemmli buffer, protein fractionated on SDS-PAGE, transferred to nitrocellulose, and immunoblotted with phospho-tyrosine 705-specific anti-Stat antibody (Cell Signaling) as per the manufacturer 's recommendations.
Western blotting
Western blotting was conducted using standard techniques and the following antibodies, listed by target: p21 (sc397-HRP, Santa Cruz); p27 (p27-HRPO, BD Pharmingen, San Diego, CA, USA); Rb (14001A, BD Pharmingen), phosphoTyr705-Stat3 (Cell Signaling).
Kinase assays
MDCK lysates immunoprecipitated with anti-cdk2 (Labvision, Freemont, CA, USA, Ab-3) were washed with IP buffer and then with kinase buffer (50 mm HEPES, pH 7. 5, 10 mm MgCl 2 , 5 mm MnCl 2 , 1 mm DTT). Samples were resuspended I in 10 ml kinase buffer with 10 ml of ATP mix (20 mm ATP, 10 mg histone, 10 mCi 34P-gamma-ATP) and incubated for 30 min at 301C. Proteins were fractionated on SDS-PAGE and exposed to film.
Growth curves and cell cycle determination
PCI-37A, UM-22B, and PCI-15B cells were seeded at 3 Â 10 4 cells/ml in 24-well plates. For each cell line, cells from duplicate wells were counted daily for 11 days using trypan blue vital dye staining. Log of cell number (normalized to day 1 cell number) was calculated. Following a 3-h BrDU pulse, the cell cycle profile was determined using dual BrdU/7AAD staining (BrDU Flow Kit, BD Plarmingen, San Diego, CA, USA) as per the manufacturer 's instructions. Analysis was performed on Coulter XL flow cytometer (Beckman-Coulter, Miami, FL, USA).
TGF-alpha stimulation and EGFR inhibition
PCI-37A cells were plated at low and high densities in DMEM containing 12%FBS. Cells were simultaneously changed to serum-free media when 'low density' cells were 50% confluent and 'high density' cells were 48 h post-100% confluence. Following 24 h of serum starvation, cells were treated with 100 nm of EGFR-specific tyrosine kinase inhibitor PD153035 (Parke-Davis Pharmaceuticals, Ann Arbor, MI, USA) for 2 h; or with 100 nm PD153035 for 2 h in addition to 30 ng/ml TGFalpha (Oncogene Research Products, Boston) during the final 30 min; or with 30 ng/ml TGF-alpha for 30 min. All treatments were in serum-free DMEM. Control cells received fresh serumfree DMEM alone. Cells were harvested by scraping and whole-cell extracts were prepared. EMSA was performed with radiolabeled hSIE duplex oligonucleotide.
TAT protein production
TAT-cdk2DN and TAT-gfp plasmids were a generous gift from Steven Dowdy. Fusion proteins were essentially prepared as described in Nagahara et al. (1998) , with the exception that fusion proteins purified on nickel columns were directly desalted on PD10 columns. Intracellular transport was verified. Fusion proteins were applied at 150 nm final concentration, reapplied 8 h later, and cells were harvested 16 h after initial addition of fusion proteins.
Gel shift assays
Gel shift assays were conducted using 15 mg of whole-cell extract in each reaction and radiolabeled hSIE duplex oligonucleotide (GATCCATTTCCCGTAAATC) as previously described (Steinman and Iro, 1999) . As indicated, Stat3 : DNA complexes were supershifted by 30 min preincubation with 4 mg anti-Stat3 antibody (Santa Cruz, sc482X).
